Vaccination against host cell-associated herpes viruses
AssigneeLohmann Animal Health GmbH & Co. KG
InventorsFrank Fehler, Klaus Osterrieder
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of so-called “host cell-associated herpes viruses,” such as Marek's disease-like virus (MDV) of poultry and Varicella Zoster virus (VZV) of man, and to vaccination against disease caused by these viruses. The invention provides a vaccine directed against an infection caused by a herpes virus that is essentially host cell-associated comprising a recombinant viral genome derived from the herpes virus, the genome allowing recombination essentially free of the host cell.
Claims19
A vaccine directed against an infection caused by a herpes virus, said herpes virus being an essentially host cell-associated herpes virus with respect to a host cell, said vaccine comprising:
- a recombinant genome derived from said herpes virus, said recombinant genome allowing recombination essentially free of said host cell.
A recombinant viral genome derived from a herpes virus that is essentially host cell associated, said recombinant viral genome allowing recombination essentially free of said host cell.
A method of treating a disease in a subject, said disease caused by an infection with an essentially host cell-associated herpes virus, said method comprising:
- administering to the subject a vaccine directed against said disease, said vaccine comprising a recombinant viral genome derived from a herpes virus that is essentially host cell associated, said recombinant viral genome allowing recombination essentially free of said host cell.
Dependencies are inferred from the claim text.